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Abstract
This consensus paper provides an overview of the state of the art in research on the 
aetiology and treatment of nightmare disorder and outlines further perspectives on 
these issues. It presents a definition of nightmares and nightmare disorder followed by 
epidemiological	findings,	and	then	explains	existing	models	of	nightmare	aetiology	in	
traumatized and non‐traumatized individuals. Chronic nightmares develop through the 
interaction	 of	 elevated	 hyperarousal	 and	 impaired	 fear	 extinction.	 This	 interplay	 is	
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1  | INTRODUCTION
Nightmare	disorder	is	defined	by	the	repeated	occurrence	of	night‐
mares that cause clinically significant distress or impairment in so‐
cial, occupational or other important areas of functioning, which are 
not attributable to the physiological effects of a substance (e.g. drug 
abuse	 or	 medication)	 and	 which	 cannot	 be	 adequately	 explained	
by	 coexisting	 mental	 and	 medical	 disorders	 (fifth	 revision	 of	 the	
Diagnostic and Statistical Manual of Mental Disorders [DSM‐5], 
American	Psychiatric	Association	[APA],	2013,	third]	revision	of	the	
International	 Classification	 of	 Sleep	Disorders	 [ICSD‐3],	 American	
Academy	of	Sleep	Medicine	[AASM],	2014).
Both	 ICSD‐3	 (AASM,	 2014)	 and	 DSM‐5	 (APA,	 2013)	 define	 a	
nightmare	as	an	“extended,	extremely	dysphoric”	dream	that	“usually	
involves efforts to avoid threats to survival, security, or physical in‐
tegrity”.	Nightmares	usually	occur	during	REM	sleep	(Nielsen,	2000;	
APA,	2013,	but	see	Solms,	2000)	and	are	associated	with	symptoms	
of physical arousal such as sweating and shortness of breath and 
more elevated indices of periodic leg movements during rapid eye 
movement	 (REM)	 sleep	 (Germain	&	Nielsen,	 2003).	 The	 prevalent	
emotion is fear, although other emotions such as anger, shame and 
sadness may also arise (Köthe & Pietrowsky, 2001; Robert & Zadra, 
2014, but see Phelps et al., 2018). These physiological symptoms 
and emotions can occur during the dreaming episode, upon awak‐
ening from the disturbing dream, or upon later recollection of the 
dream	 experience.	 One	 can	 differentiate	 between	 posttraumatic	
nightmares and idiopathic nightmares. Posttraumatic nightmares 
are either direct replications of a traumatic event or they contain 
trauma‐related emotion or content that is symbolically related to the 
trauma. Idiopathic nightmares depict stories that are more imagina‐
tive in nature and that do not necessarily reflect a traumatic event. 
Posttraumatic nightmares lead to more severe arousal, more noctur‐
nal awakenings, stronger aggression and more elevated helplessness 
than do idiopathic nightmares (Wittmann & De Dassel, 2015).
There is an ongoing debate about whether the dreamer needs 
to awaken from a dysphoric dream for the dream to be considered 
a	 nightmare	 (Robert	 &	 Zadra,	 2014).	 Although	 the	 previous	 DSM	
diagnostic	manual	(DSM‐IV,	American	Psychiatric	Association	(APA),	
1994) described “Repeated awakenings from the major sleep period 
or	naps	with	detailed	recall	of	extended	and	extremely	frightening	
dreams	[…]”,	the	more	recent	DSM‐5	(APA,	2013)	formulated	this	cri‐
terion	A	as	follows:	“Repeated	occurrences	of	extended,	extremely	
dysphoric,	and	well‐remembered	dreams	[…]”	(p.	404).	Thus,	although	
nightmares often lead to awakenings according to the DSM‐5, wak‐
ing up is not a necessary diagnostic criterion for nightmare disorder. 
There	is	no	frequency	criterion,	although	the	DSM‐5	suggests	a	mild	
nightmare disorder as less than one episode per week on average, a 
moderate disorder as one or more episodes per week, but less than 
nightly,	and	a	severe	disorder	as	nightly	episodes.	An	acute	episode	
has a duration of 1 month or less, a subacute episode a duration of 
at least 1 month but less than 6 months, and chronic nightmares en‐
dure	for	6	months	or	longer	(APA,	2013).
Contrary to night terrors that manifest with confusional arousals, 
incomplete awakenings and difficulties in being comforted, individ‐
uals diagnosed with nightmare disorder awaken completely, orient 
immediately	 and	 remember	 the	 dream	 vividly.	Nightmares	 are	 also	
frequently	misidentified	as	sleep	paralysis	and	sleep‐onset	or	sleep‐
offset hallucinations, which are commonly associated with narcolepsy, 
but	a	sleep‐paralysis	type	of	nightmares	is	recognized	(APA,	2013).
Notwithstanding	the	above	nosologies,	in	practice	it	is	rare	to	di‐
agnose a chronic nightmare disorder because practitioners are often 
unaware of the fact that chronic nightmares often constitute an inde‐
pendent mental disorder or sleep disorder or co‐occurring disorder 
with	another	psychiatric	condition.	Instead,	practitioners	frequently	
subsume most types of disturbing dreams as a secondary symptom 
to	a	primary	mental	disorder	such	as	anxiety	disorder	or	posttrau‐
matic stress disorder (PTSD, Krakow, 2006; Spoormaker, Schredl, & 
Van	Den	Bout,	2006;	Schredl,	2013;	Thünker,	Norpoth,	Von	Aspern,	
Özcan,	 &	 Pietrowsky,	 2014;	 Nadorff,	 Nadorff,	 &	 Germain,	 2015;	
Schredl	&	Göritz,	2014;	Krakow,	Kellner,	Pathak,	&	Lambert,	1995).	
Overall,	3.5%–8.3%	of	the	general	adult	population	(Li,	Zhang,	Li,	&	
Wing, 2010; Munezawa et al., 2011; Sandman et al., 2013; Schredl, 
2010),	6.7%–11.3%	of	children	 (Wiechers	et	al.,	2011)	and	15.6%–
66.7%	 of	 adult	 psychiatric	 patients	 (anxiety	 disorders	 and	 PTSD,	
assumed	to	be	facilitated	by	trait	affect	distress	elicited	by	traumatic	experiences,	early	
childhood adversity and trait susceptibility, as well as by elevated thought suppression 
and	potentially	 sleep‐disordered	breathing.	Accordingly,	 different	 treatment	options	
for nightmares focus on their meaning, on the chronic repetition of the nightmare or on 
maladaptive beliefs. Clinically, knowledge of healthcare providers about nightmare dis‐
order and the delivery of evidence‐based interventions in the healthcare system is dis‐
cussed. Based on these findings, we highlight some future perspectives and potential 
further developments of nightmare treatments and research into nightmare aetiology.
K E Y WO RD S
anxiety,	evidence‐based	medicine,	exposure,	imagery	(psychotherapy),	nightmare	scripts,	
parasomnias, posttraumatic stress disorders, PTSD, sleep‐disorders
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respectively,	Swart,	Van	Schagen,	Lancee,	&	Van	Den	Bout,	2013)	
report	 recurrent	 nightmares.	 Across	 all	 epidemiological	 findings,	
nightmares	occur	more	frequently	 in	women	than	 in	men	(Li	et	al.,	
2010; Munezawa et al., 2011; Sandman et al., 2013; Schredl, 2010; 
Swart	et	al.,	2013;	Wiechers	et	al.,	2011).	Frequent	nightmares	are	
associated with a wide range of mental complaints, sleep disruptions 
and insomnia, that is, difficulties in sleep onset and maintenance to‐
gether with compromised daytime functioning (Cattarius & Schlarb, 
2016;	 Krakow,	 2006;	 Lancee	 &	 Schrijnemaekers,	 2013;	 Lancee,	
Spoormaker,	 &	 Van	Den	 Bout,	 2010b).	 Further	 consequences	 are	
tiredness upon getting up, daytime sleepiness, lack of energy, pet‐
ulance, difficulties in concentrating, worries about having enough 
sleep	(Lancee	&	Schrijnemaekers,	2013),	increased	mental	distress,	
anxiety,	 depression	 (Blagrove,	 Farmer,	 &	Williams,	 2004;	 Levin	 &	
Fireman, 2002), poor academic performance (Wiechers et al., 2011) 
and maladaptive personality functioning (Köthe & Pietrowsky, 
2001;	Van	Schagen,	Lancee,	Swart,	Spoormaker,	&	Van	Den	Bout,	
2017).	Finally,	recurrent	nightmares	increase	the	risk	of	attempting	
and re‐attempting suicide (Sjöström, Hetta, & Waerna, 2009), even 
after	controlling	for	sex,	age,	relationship	status,	employment	status,	
smoking,	 use	 of	 alcohol,	 amount	 of	 exercise,	 symptoms	 of	 insom‐
nia,	symptoms	of	depression,	traumatic	experiences,	posttraumatic	
symptoms, other mental disorders and use of psychotropic medica‐
tion	(Nadorff,	Nazem,	&	Fiske,	2011;	Sandman	et	al.,	2017).
Given their high prevalence and associated features of impaired 
mental and physical health, nightmares are of substantial clinical rel‐
evance. Several theoretically and empirically based attempts to treat 
nightmare disorder have been developed since the 1980s. This paper 
reflects the results of an international symposium on nightmare 
treatment	 attended	 by	 scientists	 and	 practitioners	 from	 Austria,	
Canada,	Denmark,	France,	Germany,	the	Netherlands,	Switzerland,	
the United Kingdom and the United States. It outlines current 
knowledge on the aetiology and treatment of nightmare disorder. It 
further provides an outlook on current developments and relevant 
perspectives in future nightmare research and treatment.
1.1 | Assessment of nightmares and 
nightmare disorder
There	are	several	 instruments	 to	assess	nightmare	frequency	and	
nightmare	 distress.	Nightmare	 frequency	 can	 be	 assessed	 by	 the	
Nightmare	Frequency	Questionnaire	(NFQ,	Krakow,	Schrader	et	al.,	
2002).	In	addition,	current	and	childhood	nightmare	frequency	and	
the relative number of recurrent nightmares in adults are part of 
the	 Mannheim	 Dream	 Questionnaire	 (MADRE,	 Schredl,	 Berres,	
Klingauf, Schellhaas, & Göritz, 2010). To address the distress that 
is	associated	with	nightmares,	some	authors	use	a	single	question	
asking whether participants have a problem with nightmares (Wood 
&	 Bootzin,	 1990).	 Alternatively,	 psychometrically	 constructed	 in‐
struments	 such	 as	 the	 Nightmare	 Distress	 Questionnaire	 (NDQ,	
Belicki, 1992) assess general concerns about nightmares, including 
their	impact	on	sleep	quality	or	on	daytime	beliefs	and	perceptions	
(Böckermann,	Gieselmann,	&	Pietrowsky,	2014).	A	subscale	of	the	
SLEEP‐50	 assesses	 nightmare	 distress	 with	 reference	 to	 DSM‐IV	
criteria	(Lancee,	Spoormaker,	&	Van	Den	Bout,	2010a).	Other	ques‐
tionnaires focus on the impact nightmares have on social, sleep and 
health‐related	domains	and	 include	the	Nightmare	Effects	Survey	
(NES,	 Krakow	 et	al.,	 2000)	 and	 the	 Trauma	 Related	 Nightmare	
Survey	 (TRNS,	Davis	&	Wright,	2007).	The	Disturbing	Dream	and	
Nightmare	Severity	Index	(DDNSI,	Krakow,	2006)	combines	night‐
mare	frequency	and	nightmare	effects	in	adults	and	the	Nightmare	
Effects	Questionnaire	 (NEQ,	Schlarb	et	al.,	2016)	combines	night‐
mare	frequency	with	nightmare	effects	 in	adolescents	from	14	to	
18	years	 of	 age.	 Other	 instruments	 focus	 on	 anxiety	 symptoms,	
such	as	the	Van	Dream	Anxiety	Scale	(VDAS,	Agargün	et	al.,	1999),	
or	on	behavioural	consequences,	such	as	the	Nightmare	Behavior	
Questionnaire	(NBQ,	Pietrowsky	&	Köthe,	2003).
The	most	frequently	used	distress	 instrument,	 the	NDQ	(Belicki,	
1992), demonstrates that nightmare distress is more strongly associ‐
ated	with	other	mental	health	complaints,	 including	anxiety	and	de‐
pression,	 than	 is	nightmare	frequency.	Furthermore,	 the	relationship	
between	nightmare	frequency	and	well‐being	is	mediated	by	NDQ‐as‐
sessed nightmare distress (Blagrove et al., 2004) and nightmare‐specific 
treatment	reduces	both	nightmare	frequency	and	nightmare	distress,	
whereas	 non‐specific	 treatment	 only	 reduces	 nightmare	 frequency	
(Gieselmann,	Böckermann,	 Sorbi,	&	Pietrowsky,	 2017;	Van	Schagen,	
Lancee,	De	Groot,	Spoormaker,	&	Van	Den	Bout,	2015).	Against	this	
background, many authors conclude that the distress caused by the 
nightmares is more relevant to mental health than is the sheer number 
of nightmares (Belicki, 1992; Blagrove et al., 2004; Gieselmann et al., 
2017;	Levin	&	Fireman,	2002;	Van	Schagen	et	al.,	2015).
2  | NIGHTMARE AETIOLOGY
According	to	Solms’	 (2000)	neurocognitive	theory	of	dream	genera‐
tion, dreams are not mainly generated by the brainstem that controls 
REM	 sleep,	 but	 rather	 by	 complex	 forebrain	 mechanisms	 indepen‐
dently	of	the	REM‐sleep	state.	He	underpins	his	rationale	with	the	neu‐
ropsychological finding from his large clinical–anatomical study that 
“the mesocortical‐mesolimbic dopamine system plays a causal role in 
the	generation	of	dreams”	(Solms,	2000,	p.	847).	Lesions	of	these	path‐
ways	inhibit	dreaming	but	do	not	affect	REM	frequency,	duration	and	
density (Solms, 2000). Solms (1995, p. 61) understands his findings as 
providing “confirmation of the classical theory of dreams that was in‐
troduced	by	Freud	almost	one	hundred	years	ago”,	according	to	which,	
dreams provide a sleep‐protecting function that offer a gateway to the 
knowledge of the unconscious mind (Freud, 1900/2005).
Other	 research	 groups	 have	 explained	 the	 aetiology	 of	 night‐
mare disorder by (a) increased hyperarousal and (b) impaired fear 
extinction.
2.1 | Hyperarousal
The aetiology of nightmare disorder may be influenced by increased 
hyperarousal that accumulates during the day and is maintained at 
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night.	 Elevated	 hyperarousal	 is	 discussed	 as	 a	 central	 pathophysi‐
ological factor in PTSD (Buckley & Kaloupek, 2001; Kendall‐Tackett, 
2009;	Pacella,	Hruska,	&	Delahanty,	2013;	Pole,	2007),	but	also	 in	
insomnia disorder (see Riemann et al., 2010, for an integrative re‐
view). Patients diagnosed with insomnia disorder were found to pro‐
duce	more	frequent	 (micro‐)	arousals	during	REM	sleep	than	good	
sleepers	and	were	 found	 to	produce	more	 fragmented	REM‐sleep	
periods than were good sleepers (Feige et al., 2008, 2013). This hy‐
perarousal enhanced information processing and beta activity dur‐
ing	sleep	(Perlis,	Giles,	Mendelson,	Bootzin,	&	Wyatt,	1997).	So,	just	
as hyperarousal is typical for both PTSD and insomnia, it may also 
help	explain	the	aetiology	of	nightmare	disorder.
2.2 | Impaired fear extinction
Although	 normal	 sleep	 and	 dreaming	 may	 enable	 fear	 extinction	
through a process of recombining fearful memories with novel and 
dissociated	contexts,	 individuals	with	nightmare	disorder	continue	
to activate arousing memory fragments during sleep, reinforcing 
fear	memories	(Germain,	Buysse,	&	Nofzinger,	2008;	Nielsen,	2017a;	
Nielsen	&	Levin,	2007).	As	stipulated	by	the	affect	network	dysfunc‐
tion	model	(AND;	Nielsen	&	Levin,	2007),	individuals	high	in	affect	
load and affect distress are particularly prone to such impaired fear 
extinction.	“Affect	load”	is	defined	as	a	state	factor	referring	to	the	
influence of stressful and negative‐emotion‐eliciting events on one's 
capacity	to	regulate	emotions,	whereas	“affect	distress”	 is	defined	
as a trait‐like tendency to react to stressors with negative affect 
and	distress.	Neurologically,	this	process	can	be	understood	as	a	hy‐
peractive amygdala together with compromised frontal regulatory 
pathways,	particularly	of	the	medial	prefrontal	cortex	(mPFC).	A	det‐
rimental	consequence	of	this	brain	state	is	that	memory	fragments	
incompatible with negative arousal cannot be retrieved from the as‐
sociative network and fear‐laden memory fragments cannot be inte‐
grated	into	the	network.	Thus,	fear	extinction	is	impaired	(Germain	
et	al.,	2008;	Nielsen,	2017a;	Nielsen	&	Levin,	2007).
2.3 | Factors facilitating hyperarousal and impaired 
fear extinction
Several factors have been proposed as facilitating hyperarousal and 
impaired	fear	extinction	in	patients	diagnosed	with	nightmare	disor‐
der.	Although	we	are	not	able	to	draw	a	complete	picture	of	these	
facilitating factors, here we address trait affect distress as caused by 
(a)	traumatic	experiences	and	childhood	adversity,	(b)	trait	suscepti‐
bility, (c) maladaptive cognitive factors and (d) physiological factors.
2.3.1 | Traumatic experiences and 
childhood adversity
According	 to	 the	AND	model,	 fear	 extinction	 capacity	 is	 impaired	
by	 the	 consequences	of	 traumatic	 experiences,	 although	develop‐
mental stress such as early childhood adversity may initiate some 
similar mechanisms. Childhood adversity is known to induce changes 
in mPFC–amygdala circuits, which are associated with heightened 
threat perception (Ochsner & Gross, 2005) and, presumably, dys‐
phoric	 dreaming	 (Nielsen	 &	 Levin,	 2007).	 Accordingly,	 childhood	
adversity may disrupt the normal development of emotion regula‐
tion,	including	emotional	expression,	and	thus	reinforce	the	develop‐
ment of a fear memory. This theory was recently articulated by the 
stress	acceleration	hypothesis	of	nightmares	(SAH,	Nielsen,	2017a).	
The	SAH	model	suggests	that	memories	of	early	events,	which	are	
normally suppressed after the infantile amnesia period (Madsen & 
Kim,	2016),	may	exert	a	persistent	influence	on	dreaming	and	waking	
memory. Supporting evidence comes from clinical (Hartmann, 1991) 
and	empirical	work	(Nielsen,	2017b)	demonstrating	that	nightmare	
sufferers have an unusually good memory of early childhood events. 
Likewise,	a	history	of	severe	childhood	maltreatment	 is	associated	
with	more	frequent	disturbed	dreams,	higher	nightmare	distress	and	
heightened psychopathology (Duval, Mcduff, & Zadra, 2013), and 
the severity and amount of trauma are both correlated with several 
dream and pathology measures (Yu, 2014). Such results are consist‐
ent	with	the	assumption	that	both	traumatic	experiences	and	early	
childhood adversity facilitate affect distress and the development of 
a	nightmare	disorder	(Nielsen,	2017a;	Nielsen	&	Levin,	2007).
2.3.2 | Trait susceptibility
The	 theory	 of	 differential	 susceptibility	 (Carr	 &	 Nielsen,	 2017,	 c.f.	
Belsky & Pluess, 2009) is consistent with the developmental ten‐
ets	of	 the	AND	and	SAH	models,	which	suppose	 that	 traumatic	ex‐
periences and early childhood adversity augment trait sensitivity in 
susceptible individuals. However, it stipulates further that such trait 
sensitivity is responsive not only to negative, but also to positive or 
supportive	 contexts.	 Empirically,	 higher	 novelty	 seeking	 and	 re‐
ward‐related behaviours were found to characterize those suffering 
from nightmare disorder and anticipatory worry (Perogamvros et al., 
2015).	Furthermore,	 individuals	with	 frequent	nightmares	display	an	
increased depth of processing of both negative and positive semantic 
stimuli	(Carr,	Blanchette‐Carrière,	Marquis,	Ting,	&	Nielsen,	2016),	and	
display more errors in response to both negative and positive distrac‐
tors on an emotional Stroop task (Simor, Pajkossy, Horváth, & Bódizs, 
2012). These studies suggest not only that trait susceptibility may fa‐
cilitate affect distress and the development of a nightmare disorder but 
also that nightmare sufferers are sensitive to both negatively and posi‐
tively toned emotional stimuli. Their sensitivity to positive stimuli may 
make them particularly susceptible to positive psychology, supportive 
social environments and other interventions that enhance emotion 
regulation,	such	as	mindfulness	training	(Carr	&	Nielsen,	2017).
2.3.3 | Maladaptive beliefs
Maladaptive beliefs may play a role in the aetiology of nightmare dis‐
order. Current research addressing the volitional attempt to suppress 
unwanted	 thoughts	 and	 feelings	 (“thought	 suppression”)	 finds	 that	
such attempts increase the likelihood that the suppressed thoughts 
reoccur	in	a	person's	dreams,	especially	those	in	REM	sleep	(Wegner,	
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Wenzlaff, & Kozak, 2004). Furthermore, the intentional avoidance of 
internal	 and	external	 stimuli	 is	 associated	with	 the	presence	of	 re‐
current	nightmares	(Kramer	&	Kinney,	2003).	In	experimental	trials,	
deliberate	thought	suppression	and	subsequent	dream	rebound	were	
enhanced by cognitive load (Bryant, Wyzenbeek, & Weinstein, 2011) 
and	deliberate	thought	suppression	worsened	sleep	quality	and	men‐
tal health, when practised over a period of 1 week (Kröner‐Borowik 
et al., 2013). Thus, deliberate thought suppression may be another 
trigger that facilitates the development of nightmare disorder.
2.3.4 | Physiological factors
One	physiological	factor	that	may	explain	some	aspects	of	hypera‐
rousal	in	nightmare	patients	and	which	may	impede	fear	extinction	
is the severe sleep fragmentation caused by obstructive and cen‐
tral	 sleep	 apnea	 (OSA	 and	CSA),	 by	 its	 subtler	 variant	 referred	 to	
as	upper	airway	resistance	syndrome	(UARS)	or	by	complex	sleep‐
related	hypoventilation	syndromes.	It	is	noteworthy	that	OSA,	CSA	
or	 UARS	 occur	 in	 unusually	 high	 rates	 in	 PTSD	 patients	 (Jaoude,	
Vermont,	Porhomayon,	&	El‐Solh,	2015;	Krakow,	Melendrez	et	al.,	
2002) and lead to (micro‐) awakenings. Several studies have drawn 
an association between sleep‐disordered breathing and night‐
mares,	 and	 treatment	with	positive	airway	pressure	 therapy	 (PAP;	
Bahammam,	 Al‐Shimemeri,	 Salama,	 &	 Sharif,	 2013;	 Krakow	 et	al.,	
2000)	and	mood	stabilizers	(Gupta,	2017)	improved	both	OSA/CSA/
UARS	and	PTSD	symptoms,	including	nightmares.
At	 the	 same	 time,	 drugs	 influencing	 the	 neurotransmitters	
norepinephrine, serotonin and dopamine are associated with the 
occurrence of nightmares in some patients, whereas compounds 
affecting	the	neurotransmitters	gamma‐aminobutyric	acid	(GABA),	
acetylcholine and histamine are less likely to induce nightmares, 
although not all results are consistent on this point. Furthermore, 
withdrawal	 from	 REM‐sleep‐suppressing	 medications	 has	 been	
reported to cause nightmares (Morgenthaler et al., 2018; Pagel & 
Helfter, 2003). Together, these findings suggest that there are che‐
mosensoric pathways that facilitate the occurrence of nightmares.
2.4 | The formation of nightmare scripts
All	the	above	factors	may	contribute	to	the	condensing	of	recurrent	
nightmare elements into a nightmare script. For some individuals, 
nightmares are thought to persist as a learned behaviour, that is, 
they	have	developed	a	“life	of	their	own”	(e.g.	Ehlers	&	Clark,	2000;	
Hartmann,	 1996;	 Krakow	 &	 Neidhardt,	 1992).	 More	 recently,	 ac‐
cording to the cognitive model of recurrent dreams (Spoormaker, 
2008), the persistence of nightmares is caused by loops of replaying 
fixed	 expectation	 patterns	 (i.e.	 nightmare	 scripts),	 even	when	 the	
original stressor that first initiated the nightmare has long faded. 
In this respect, nightmares occur when a nightmare script is acti‐
vated in response to dream elements that are similar to the original 
stressor; the nightmare is thus perpetuated in its habitual form.
Taken together, the preceding nightmare‐inducing factors consti‐
tute a pathophysiologic patchwork, which is summarized in Figure 1.
3  | THE TREATMENT OF NIGHTMARE 
DISORDER
Untreated, nightmare disorder often persists for decades 
(Schreuder, Kleijn, & Rooijmans, 2000) and, although specific 
treatment	approaches	exist,	patients	are	often	not	treated	or	are	
inadequately	treated	(Krakow	et	al.,	1995).	The	following	consid‐
erations may help focus attention on the main impacts of different 
treatment approaches; these are treatments that emphasize: (a) 
the subjective meaning of nightmares, (b) the pathologic repetition 
of the nightmares and (c) maladaptive beliefs about nightmares.
3.1 | Treatment approaches targeting the 
meaning of nightmares
The particular meaning of a nightmare is one focus in psychody‐
namic approaches. Given that posttraumatic nightmares are often 
described by patients as having stereotypic replicative content 
(Wittmann,	Schredl,	&	Kramer,	2007),	many	treatment	approaches	
neglect the potential subjective meanings of this replicative con‐
tent.	Yet,	Lansky	and	Bley	 (1995)	 reported	extensive	clinical	evi‐
dence that so‐called replicative nightmares may differ from the 
original episodic trauma memory and constitute an important 
source of information. From a psychodynamic perspective, the 
occurrence of nightmares could be considered an alarm signal 
for	 a	 disturbance	 of	 current	 psychic	 equilibrium	 and	 psychody‐
namic approaches could aim to identify and solve the underlying 
conflicts rather than addressing the alarm signal alone. This work 
includes processing of multiple levels, such as the developmen‐
tal and trauma history of an individual (Wittmann & De Dassel, 
2015), discovering similarities and differences to episodic memory 
traces	(Lansky	&	Bley,	1995),	relating	the	occurrence	of	nightmares	
to therapeutic processes, current life situation and interpersonal 
patterns (Wittmann & De Dassel, 2015), making sense of repeti‐
tions (Gardner & Ørner, 2009), and elaborating implicit meanings in 
order to gain insight into one's affect regulation processes (Moser 
& Von Zeppelin, 1996).
Changes in dream content were found to correspond to the ad‐
aptation	versus	maladaptation	that	patients	experienced	after	trau‐
matic events (Mellman, David, Bustamante, Torres, & Fins, 2001; 
Terr, 1983) and to indicate symptom changes and personal growth 
in the course of psychoanalytic treatment. However, evidence of the 
effectiveness of psychodynamic approaches in treating nightmares 
is restricted to uncontrolled case series (e.g. Gardner & Ørner, 2009; 
Lansky	&	Bley,	1990;	Wittmann	&	De	Dassel,	2015).
3.2 | Treatment approaches targeting the chronic 
repetition of nightmares
Treatment approaches that address the chronic repetition of night‐
mare content often consider nightmares to be an overlearned behav‐
iour and aim to unlearn these habits. These approaches are mainly 
based	on	the	principles	of	(a)	desensitization	and	exposure	therapy,	
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(b) imagery rehearsal therapy (IRT) or (c) lucid dreaming, as described 
below.
3.2.1 | Desensitization and exposure therapy
Desensitization	 and	 exposure	 therapy	 were	 the	 first	 approaches	
used	 to	 treat	 nightmares	 directly	 (Kellner,	 Neidhardt,	 Krakow,	 &	
Pathak,	1992;	Miller	&	Dipalato,	1983).	For	a	desensitization	exer‐
cise,	the	patient	is	first	introduced	to	muscular	relaxation.	Then	he/
she is asked to imagine the nightmare, without modifying it, and to 
relax	whenever	it	causes	tension.	During	exposure	therapy,	the	pa‐
tient is also asked to imagine the nightmare vividly but without an 
accompanying	relaxation	exercise	and	also	without	actively	chang‐
ing	the	story	line	(Kunze,	Arntz,	Morina,	Kindt,	&	Lancee,	2017).	This	
method	 is	 adapted	 from	 traditional	 techniques	 for	 treating	 PTSD	
(e.g. Foa & Rothbaum, 1989). The common treatment rationales of 
desensitization	and	exposure	therapy	are	based	on	the	principles	of	
extinction	and/or	inhibitory	learning,	by	which	the	symptoms	of	fear	
and arousal accompanying the nightmare are overridden by more 
adaptive behavioural, cognitive and emotional processes. Several 
trials have demonstrated the effectiveness of desensitization and 
exposure	therapies	(Davis	&	Wright,	2007;	Hansen,	Höfling,	Kröner‐
Borowik,	Stangier,	&	Steil,	2013).	Kunze	et	al.	(2017)	showed	a	pure	
exposure	 protocol	 had	 similar	 effect	 sizes	 to	 a	 pure	 IRT	 protocol.	
However,	one	major	disadvantage	of	desensitization	and	exposure	
therapies is that the arousal elicited during treatment may cause se‐
vere	distress	in	the	patient	(Arntz,	Tiesema,	&	Kindt,	2007,	but	see	
Kunze	et	al.,	2017).
3.2.2 | Imagery rehearsal therapy (IRT)
The IRT approach to treating nightmares is underpinned by the best 
available	evidence	and	therefore	recommended	as	level	A	treatment	
for	 nightmare	 disorder	 by	 the	Oxford	 Centre	 for	 Evidence	 Based	
Medicine (Cranston, Davis, Rhudy, & Favorite, 2011), as well as by 
the	AASM	(Aurora	et	al.,	2010;	Morgenthaler	et	al.,	2018).	With	IRT,	
patients are instructed to rescript the story of the nightmare during 
wakefulness. The original instruction was to: “Change the nightmare 
anyway	 you	wish”	 (Kellner	 et	al.,	 1992),	which	 offered	 no	 specific	
targeting of the nightmare's ending or any other specified compo‐
nent of the disturbing dream, whereas others have proposed to 
change	the	nightmare	to	possess	a	“triumphant”	(Marks,	1978),	“sat‐
isfactory”	or	“more	neutral	or	even	pleasant”	(Thünker	&	Pietrowsky,	
2012) ending. This rescripted nightmare (which no longer appears 
to	 be	 a	 nightmare)	 is	 then	 rehearsed	 in	 the	 patients’	 imagination	
a couple of times each day. In their meta‐analysis, Hansen et al. 
(2013) reported large pre–post within‐group effect sizes for IRT for 
nightmare	 frequency	 (Hedges’	 g = 1.04) and nights per week with 
nightmares (g = 0.99,	 gs	≥	0.80	 are	 considered	 a	 large	 effect)	 (see	
Augedal,	Hansen,	Kronhaug,	Harvey,	and	Pallesen	(2013),	Cranston	
et	al.	 (2011),	 Casement	 and	 Swanson	 (2012),	 Nadorff,	 Lambdin,	
and Germain (2014), Seda, Sanchez‐Ortuno, Welsh, Halbower, and 
Edinger	 (2015),	 for	 comparable	 results	 of	 other	 meta‐analyses).	
IRT	 not	 only	 decreased	 nightmare	 frequency,	 but	 also	 decreased	
PTSD severity (g	=	0.92,	Hansen	et	al.,	2013),	increased	sleep	qual‐
ity (Cohen's d = 0.68, Casement & Swanson, 2012) and decreased 
more	general	mental	health	complaints.	Neither	adverse	effects	nor	
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symptom substitutions were reported in patients being treated with 
IRT.
There is an ongoing debate about active treatment mechanisms 
in IRT. Because IRT is most often offered in a multicomponent 
treatment package, specific treatment mechanisms are difficult to 
identify:	 nightmare	 modification	 rarely	 occurs	 without	 any	 expo‐
sure	 to	 the	 aversive	nightmare	 content	 (Lancee,	Van	Den	Bout,	&	
Spoormaker, 2010) and most treatment manuals also include psy‐
cho‐education,	the	keeping	of	sleep	diaries,	relaxation	exercises	and	
imagination	techniques	taken	from	the	treatment	of	PTSD.	Attempts	
to identify such treatment components have demonstrated that 
the simple recording of nightmares in a diary decreases nightmare 
frequency	and	nightmare	distress	(Lancee	et	al.,	2010a;	Neidhardt,	
Krakow, Kellner, & Pathak, 1992); nonetheless, IRT as an adjunct 
therapy outperformed a comparison treatment that also included 
diaries	 (Gieselmann	et	al.,	2017;	Van	Schagen	et	al.,	2015).	On	 the	
other hand, keeping detailed narrative sleep diaries was as effective 
as	IRT	(with	the	diaries)	in	decreasing	nightmare	frequency,	whereas	
IRT outperformed detailed diaries in reducing nightmare distress. 
Interestingly, a pure IRT protocol stripped of any other treatment 
components such as diaries or homework assignments, and only 
including a minimum amount of psycho‐education, was also effec‐
tive	(Kunze	et	al.,	2017).	Thus,	the	keeping	of	diaries	may	not	be	a	
necessary treatment component of IRT. Furthermore, it has been 
argued	that	exposure	to	nightmare	content	is	not	a	necessary	treat‐
ment	component,	as	IRT	is	effective	with	minimal	exposure	(Krakow,	
Hollifield et al., 2001). However, some studies suggest that an inter‐
vention	of	relaxation	training	and	sleep	habit	modification	does	not	
perform	worse	than	the	full	IRT	protocol	including	exposure	and	re‐
scripting (Miller & Dipalato, 1983; Pruiksma, Cranston, Rhudy, Micol, 
& Davis, 2018). The literature thus remains unclear and sometimes 
conflicting.
3.2.3 | Lucid dreaming
Lucid	dreaming	therapy	takes	a	notably	different	approach,	focus‐
ing on enabling individuals to influence their dreams directly while 
dreaming	 (Holzinger,	 2014).	 A	 lucid	 dream	 is	 characterized	 by	 an	
awareness of orientation, that is, of being in the process of dream‐
ing; it is often also accompanied by an awareness of being able 
to make decisions and therefore to take charge of or responsibil‐
ity for the dream plot. This may lead to the ability to act volition‐
ally;	 for	 example,	 to	 alter	 or	 even	 control	 the	 dream's	 content	 or	
to simply wake oneself up. In practice, patients are invited to go to 
bed	with	 the	explicit	 intent	 to	 improve	their	dream	recall	by	writ‐
ing	down	their	dreams	directly	upon	awakening.	Also,	adopting	the	
conviction that one can realize when one is dreaming was found 
to	 increase	 the	 frequency	 of	 lucid	 dreams.	 Checking	 whether	 or	
not one has become lucid can be encouraged during wakefulness 
with	 reality	 testing	methods	 that	are	 repeated	 frequently:	 ‘‘Is	 this	
really	 happening	 or	 am	 I	 dreaming?’’,	 ‘‘When	 I	 look	 at	 something	
twice, does it still look the same (e.g. Does the clock still indicate 
the	same	time	or	not?	Is	the	book	title	still	the	same	or	is	it	not)?’’	
Lucid	dreaming	as	an	add‐on	to	Gestalt	 therapy	was	found	to	 im‐
prove	nightmare	and	sleep‐related	symptoms	more	quickly	than	was	
Gestalt	therapy	without	explicit	focus	on	the	nightmares	(Holzinger,	
Klösch, & Saletu, 2015). However, one major concern was that not 
every dreamer is able to reach the lucid dreaming state, as demon‐
strated	by	Spoormaker	and	Van	Den	Bout	(2006),	where	only	six	of	
16 patients were able to become lucid in a nightmare. Interestingly 
though, treatment effects occurred independent of whether or not 
patients were able to become lucid in their dreams. Meanwhile, a 
mere introduction to the concept of lucid dreaming was found to 
cause relief (Holzinger et al., 2015).
3.3 | Treatment approaches targeting 
maladaptive beliefs
Another	aspect	seldom	targeted	in	theory	and	practice	is	the	holding	
of maladaptive beliefs. Does maladaptive ruminating and catastro‐
phizing	 (e.g.	 “After	 a	 nightmare,	 I	 am	drenched	 in	 sweat”,	 “After	 a	
night	with	nightmares,	the	next	day	will	be	a	torture”)	have	an	impact	
on	 patients’	 distress?	 Do	 maladaptive	 idiosyncratic	 models	 about	
the meaning of nightmares (e.g. “I need the nightmares to prepare 
for	future	events	in	real	life”)	help	or	hurt	treatment	effectiveness?	
Do changes in these beliefs decrease distress? Harvey, Tang, and 
Browning (2005) introduced cognitive therapy for the treatment of 
insomnia. In this vein, they recommend changing maladaptive beliefs 
by	means	of	 behavioural	 experiments	 and	 cognitive	 restructuring.	
Negative	self‐ascriptions	are	also	addressed	in	the	original	IRT	pro‐
tocol	(Krakow	&	Zadra,	2006),	and	both	exposure	and	IRT	protocols	
were able to ameliorate negative beliefs about nightmares (Kunze 
et	al.,	 2017).	 Paradoxical	 intention,	 that	 is,	 encouraging	 nightmare	
sufferers to have nightmares, has been recommended as a strategy 
to tackle negative appraisals in recurrent nightmares (Spoormaker, 
2008).
3.4 | Active treatment mechanisms of direct 
nightmare treatment
In	 their	 attempt	 to	 explain	 reported	 effects	 of	 specific	 nightmare	
treatments,	Rousseau	and	Belleville	(2018)	conducted	a	qualitative	
analysis and concluded that increased feelings of mastery, as pro‐
posed by Germain et al. (2004) and Krakow, Hollifield et al. (2001), 
was the most often cited mechanism. The authors state that the con‐
viction that one is in control of one's nightmares does include cogni‐
tive	elements	but	also	emotional	processing.	Emotional	processing	
leads to memory consolidation, that is, a reorganization of conscious 
and unconscious fear structures in the memory network. They dis‐
cussed	their	approach	with	reference	to	the	AND	model	(Nielsen	&	
Levin,	2007).	Beyond	that,	mechanisms	similar	to	emotional	process‐
ing are also discussed as active treatment mechanisms in the treat‐
ment of PTSD (see below, c.f. Kleim et al., 2013), as well as in relation 
to	REM	sleep	as	a	facilitating	factor	in	the	restructuring	of	cognitive‐
affective memory content in overcoming hyperarousal (Feige et al., 
2008,	2013;	Perlis	et	al.,	1997;	Riemann	et	al.,	2010).
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3.5 | Pharmacological treatment
Regarding the specific pharmacological treatment of nightmares, 
most	trials	have	made	use	of	prazosin,	a	CNS	active	alpha‐1	adreno‐
receptor	 antagonist.	 The	AASM	 recommended	 prazosin	 as	 an	 ad‐
junct	therapy	for	PTSD,	including	nightmares	(Aurora	et	al.,	2010,	on	
behalf	of	the	AASM).	However,	there	was	a	recent	large‐scale	multi‐
centre trial that did not yield any improvements (Raskind et al., 2018) 
and another trial in which patients returned to their baseline levels 
after treatment was discontinued (Raskind et al., 2018). These con‐
flicting	data	caused	the	AASM	to	downgrade	their	advice	regarding	
prazosin	from	“recommended”	to	“may	be	used”	and	to	name	other	
pharmaceuticals	 that	 “may	 be	 used”	 as	 well	 (Morgenthaler	 et	al.,	
2018,	on	behalf	of	the	AASM).
When evaluating the effects of pharmacological treatment, one 
should take into account that pharmaceuticals are commonly tested 
against placebos in a double‐blinded manner. Given that most psy‐
chotherapy trials deliver narrative‐based interventions, they often 
cannot meet these high standards: Therapists are commonly aware 
of the group the patients are randomized to and most interventions 
are tested against waiting‐list control conditions which cannot be 
compared	with	a	placebo	pill.	At	the	same	time,	there	are	currently	
no pharmaceuticals that can be recommended without reservation 
for the treatment of nightmare disorder.
4  | NIGHTMARE TREATMENT IN 
DIFFERENT PATIENT POPULATIONS
4.1 | Nightmare treatment in PTSD
Up	to	67%	of	patients	diagnosed	with	PTSD	re‐experience	intrusive	
trauma memories in the form of distressing dreams. Further, the 
sleep fragmentation associated with nightmares is likely to inter‐
fere with recovery from PTSD symptoms (Babson & Feldner, 2010; 
Germain et al., 2008; Harvey, Jones, & Schmidt, 2003).
Just as with idiopathic nightmares, IRT is a powerful strat‐
egy	 for	 the	 treatment	 of	 nightmares	 in	 PTSD	 patients.	 A	 sin‐
gle session including IRT in victims of violent crimes (Germain, 
Shear,	 Hall,	 &	 Buysse,	 2007)	 as	well	 as	 IRT	without	 any	 add‐on	
procedures	 in	 sexual	 assault	 survivors	 improved	both	nightmare	
symptoms and other sleep parameters (Krakow, Hollifield et al., 
2001). Furthermore, IRT was found to generalize to other PTSD 
symptoms without directly targeting them, that is, by causing im‐
provements in intrusive, avoidance and arousal symptoms (Seda 
et	al.,	2015).	Numerous	studies	show	significant	effects	of	IRT	on	
nightmares	and	PTSD	symptoms	(e.g.	Nappi,	Drummond,	Thorp,	&	
Mcquaid,	2010).
When comparing the short‐term effects of prazosin versus IRT 
(Seda et al., 2015), both were found to show comparable and mod‐
erate effects on nightmares and PTSD symptoms, but studies that 
combined IRT with CBT for insomnia (CBT‐i) performed better at 
improving	 overall	 sleep	 quality	 compared	 to	 those	 using	 prazosin.	
IRT studies show considerably more heterogeneity and variation in 
treatment protocol delivery (e.g. combining IRT with CBT‐i or with 
other types of psychological interventions), which may influence re‐
sults. Initial findings from controlled studies show that CBT‐i alone 
(Ho, Chan, & Tang, 2016), as well as CBT‐i combined with IRT, effec‐
tively reduces insomnia and PTSD symptoms (Margolies, Rybarczyk, 
Vrana,	Leszczyszyn,	&	Lynch,	2013).
4.2 | Nightmare treatment in patients with diverse 
other mental disorders
IRT	 had	moderate	 effects	 on	 nightmare	 frequency	 and	 nightmare	
distress when used as an add‐on treatment in outpatients with 
diverse mental disorders. These patients improved more in night‐
mare	 frequency	 and	 nightmare	 distress	 than	 did	 patients	who	 re‐
ceived treatment as usual (Van Schagen et al., 2015). Improvements 
were maintained in the long term, that is, at 6‐ and 9‐months fol‐
low‐up	(Van	Schagen,	Lancee,	Spoormaker,	&	Van	Den	Bout,	2016).	
Furthermore, treating nightmares as an add‐on to a standard inpa‐
tient psychiatric treatment also leads to greater reductions in suicidal 
ideation	(Ellis,	Rufino,	&	Nadorff,	2019).	Thus,	nightmare	treatment	
may help improve treatment outcome in general psychiatric prac‐
tice. On the other hand, treatment effects were found to vary across 
patients with and without comorbidities: higher comorbidities pre‐
dicted worsened treatment outcome (Thünker & Pietrowsky, 2012).
4.3 | Nightmare treatment in refugees
Refugees are another population that often suffers from diverse 
mental disorders, including recurrent nightmares. Their number 
reached	a	new	peak	by	 the	end	of	2017,	with	 a	 total	 of	25.4	mil‐
lion	 refugees	 worldwide	 (United	 Nations	 High	 Commissioner	 for	
Refugees	 (UNHCR),	2018).	 It	 is	estimated	that	roughly	30%	of	the	
world's	 refugees	 suffer	 from	 PTSD.	 In	 a	 sample	 of	 752	 trauma‐ 
affected refugees undergoing psychiatric treatment at an outpatient 
ambulance service in Denmark in 2008 to 2012, 99% reported sleep 
disturbances and recurrent nightmares as their most prevalent symp‐
toms	 (Sandahl,	 Vindbjerg,	 &	 Carlsson,	 2017).	 However,	 common	
treatment manuals cannot account for the special circumstances 
experienced	by	refugees,	such	as	the	language,	cultural	and	organi‐
zational barriers that complicate effective treatment. In the case of 
refugees’	nightmares,	preliminary	investigations	have	addressed	the	
effects of prazosin (Boynton, Bentley, Strachan, Barbato, & Raskind, 
2009) and clonidine (Kinzie, Sack, & Riley, 1994).
4.4 | Nightmare treatment in children and 
adolescents
Nightmares	and	other	parasomnias	are	frequently	reported	in	chil‐
dren and adolescents. Often children and adolescents are not only 
afraid	of	nightmares,	but	also	of	sleeping	alone,	or	express	fears	of	
the	dark	(Wiechers	et	al.,	2011).	Frequently,	not	only	the	child	but	at	
least one other member of the family will suffer from non‐restora‐
tive sleep because of the child's sleep (Cattarius & Schlarb, 2016). 
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Symptoms usually decrease with advancing age. Yet, the presence 
of nightmares at the age of 8–11 years was predictive of having 
nightmares 2 years later, indicating that nightmares at an earlier 
age are likely to remain years later (Schredl, Fricke‐Oerkermann, 
Mitschke,	 Wiater,	 &	 Lehmkuhl,	 2009).	 Diverse	 treatment	 tech‐
niques	have	been	reported	for	use	with	children	and	adolescents,	
including	systematic	desensitization,	IRT,	relaxation	techniques,	ex‐
tinction and eye movement desensitization; however, findings are 
mainly restricted to case studies and trials with small sample sizes 
(see Sadeh, 2005 for a review on sleep disorders in children and 
adolescents). Various studies applying combined treatments to ad‐
dress mainly insomnia showed significant decreases in nightmare 
symptoms for children aged up to 4 years (Schlarb, Brandhorst et al., 
2011), in children aged 5 to 10 years (Schlarb, Velten‐Schurian et al., 
2011)	 and	 in	 university	 students	 (Schlarb	 et	al.,	 2017).	 Regarding	
treatment targeting nightmares specifically, IRT showed a signifi‐
cantly	reduced	nightmare	frequency	in	children	aged	6	to	11	years	
(Simard	 &	 Nielsen,	 2009)	 and	 in	 children	 aged	 13	 to	 18	years	
(Krakow, Sandoval et al., 2001).
5  | LACK OF KNOWLEDGE ABOUT 
NIGHTMARE SUFFERING AND TREATMENT 
AVAILABILITY
Despite	the	fact	 that	up	to	70%	of	patients	 in	psychiatric	samples	
suffer from recurrent nightmares (Swart et al., 2013; Van Schagen 
et	al.,	2017),	nightmare	screenings	and	treatments	remain	rare,	even	
in	 sleep	 centres.	 Nonetheless,	 nightmares	 can	 be	 treated	 with	 a	
minimum‐contact intervention. The treatment of nightmare disor‐
der	has	been	effective	with	a	single	session	(Neidhardt	et	al.,	1992),	
with	posted	self‐help	books	 (Burgess,	Marks,	&	Gill,	1998;	Lancee,	
Spoormaker,	&	Van	Den	Bout,	2011;	Lancee	et	al.,	2010a)	and	with	
Internet‐based	self‐help	(Gieselmann	et	al.,	2017).	However,	the	ma‐
jority of nightmare sufferers do not seek professional help. Many 
patients choose to live with their nightmares, often because they 
are	not	aware	of	any	other	option.	Less	than	one‐third	believed	their	
nightmares are treatable and only 38% reported them to a healthcare 
provider	(Nadorff	et	al.,	2015;	Schredl,	2013;	Thünker	et	al.,	2014).	If	
help was sought, most patients consulted general practitioners (41%) 
or	medical	specialists	 (38%),	who	possessed	scant	expertise	 in	the	
treatment	of	nightmare	disorder.	Less	than	one‐third	to	one‐fifth	of	
nightmare sufferers who sought professional help reported having 
received	helpful	advice	(Nadorff	et	al.,	2015;	Schredl	&	Göritz,	2014;	
Thünker et al., 2014).
6  | FUTURE PERSPECTIVES
Nightmare	aetiology	and	treatment	are	still	relatively	new	fields	and	
numerous	 research	 questions	 remain	 unanswered.	 Thus,	 the	 last	
section will present possible future perspectives regarding (a) the 
aetiology of nightmare disorder, (b) the continued development of 
nightmare treatments, (c) application of nightmare treatments to 
different subpopulations and (d) the integration of nightmare treat‐
ments into the healthcare system.
6.1 | Future perspectives regarding the aetiology of 
nightmare disorder
From a basic science perspective, research on nightmares is often 
hampered by the fact that the occurrence of nightmares solely 
depends on subjective reports. However, many other phenomena 
have similar issues of subjectivity (e.g. fear, pain, mind‐wandering, 
episodic memory, consciousness) that do not prevent the develop‐
ment	of	 valid	 experimental	models	 and	assessment	 tools	 to	 study	
various aspects of the topic. Thus, (a) we should more clearly define 
nightmare criteria that help to objectify common agreement. Given 
the fact that nightmare distress is a key feature of nightmare disor‐
der, the diverse number of assessment tools limits the comparability 
of nightmare distress across different trials and well established in‐
struments have been criticized for methodological reasons (Schredl, 
Landgraf,	&	Zeiler,	2003).	Thus,	a	common	consensus	on	how	to	de‐
fine nightmare criteria and how to operationalize nightmare distress 
is warranted. Furthermore, (b) the fields of psychoneuroimmunol‐
ogy and psychoneuroendocrinology (Buckley & Kaloupek, 2001; 
Kendall‐Tackett,	 2009;	 Pacella	 et	al.,	 2013;	 Pole,	 2007)	 may	 help	
provide further insight into the distress evoked by nightmares and 
probable causal relationships between psychoneuroimmunologic 
and psychoneuroendocrinologic mechanisms and nightmare occur‐
rence. Here, the role of nightmare‐inducing medications may help 
clarify	such	mechanisms,	although	results	are	mixed	as	nightmares	
occur in some patients but not in others. (c) The interplay between 
the pathophysiology of sleep‐disordered breathing and nightmares 
may add another layer of understanding from the basic science 
framework	(Gupta,	2017;	Jaoude	et	al.,	2015).
We	propose	 that	 in	developing	experimental	models	 for	night‐
mares, much can be learned from the adjacent fields of hyperarousal 
and	 fear	extinction.	Regarding	hyperarousal,	EEG	studies	are	war‐
ranted to clarify whether phenomena such as (micro‐) arousals 
during	REM	sleep	and	REM	sleep	fragmentation	(Feige	et	al.,	2008,	
2013) are also observed in nightmares. Furthermore, there must be 
clarification	of	why	patients	with	insomnia	disorder	more	frequently	
perceive	REM	 sleep	 as	 being	 awake,	whereas	 patients	with	 night‐
mare	 disorder	 more	 frequently	 perceive	 nightmares	 during	 REM	
sleep.	 The	 theory	 formulated	 above	 that	 impaired	 fear	 extinction	
and elevated hyperarousal are necessary to elicit nightmares remains 
hypothetical and should be investigated empirically. Regarding fear 
extinction,	 opportunities	 for	 knowledge	 translation	 from	 afflicted	
individuals to healthy individuals, and from animals to human beings, 
are	encouraged	by	strong	overlap	in	both	experimental	procedures	
and underlying neural circuitry. However, the unconditioned stim‐
uli used in studies with humans are commonly mild electric shocks 
to the wrist and to our knowledge, this does not result in intrusive 
memory traces in human subjects (e.g. flashbacks and spontaneous 
thoughts about the aversive event). Thus, a standard fear‐learning 
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paradigm may prove to be suboptimal for studying intrusive memo‐
ries and nightmares in humans.
Interestingly, several research groups have started to address 
relations between fear conditioning and intrusive memory forma‐
tion by using highly aversive film clips as unconditioned stimuli, for 
instance, with brief film fragments (Wegerer, Blechert, Kerschbaum, 
& Wilhelm, 2013) or reminder cues of previously watched long‐dura‐
tion	movies	(Kunze,	Arntz,	&	Kindt,	2015).	Moreover,	there	is	an	in‐
creasing focus on the effects of emotional stimuli (film fragments) on 
sleep parameters (Talamini, Bringmann, De Boer, & Hofman, 2013; 
Werner,	Schabus,	Blechert,	Kolodyazhniy,	&	Wilhelm,	2015).	A	cen‐
tral	question	remains	the	extent	to	which	fear‐conditioned	intrusive	
memory traces are subjectively reported during the night, because 
their spontaneous occurrence in the daytime does not necessarily 
imply spontaneous occurrence during sleep. This research on fear 
conditioning	 and	 fear	 extinction	 could	 be	 an	 interesting	 topic	 for	
examining	 individual	 differences;	moreover,	 future	 research	 could	
increase	experimental	control	 in	 the	sleep	 laboratory	by	means	of	
external	stimulation	methods.
Additionally,	a	better	understanding	of	the	role	of	thought	sup‐
pression is warranted. To date, the impact of thought suppression in 
idiopathic and posttraumatic nightmares can be considered as the 
most speculative among all discussed concepts. In posttraumatic 
nightmares, cognitive avoidance was not found to predict night‐
mare	 frequency	 (Babson	 et	al.,	 2011),	 although	 it	 remains	 unclear	
whether cognitive avoidance is congruent with what is subsumed 
under thought suppression. Yet, the available theoretical frame‐
works could guide the development of testable research procedures 
to address the role of thought suppression and cognitive avoidance 
in both idiopathic and posttraumatic nightmares.
6.2 | Future perspectives regarding the treatment of 
nightmare disorder
6.2.1 | The case of different treatment approaches
Despite medium to large effect sizes, there is still room for im‐
provement of treatment outcomes. In particular, the large variance 
across the different work groups (Hansen et al., 2013) is still not well 
understood.
Alternative	treatments	to	IRT	should	be	considered	and	studied	
further. More precise knowledge is needed regarding the effects 
of pharmaceutical treatments, which will enable the formulation of 
more precise recommendations. Furthermore, RCTs should be de‐
veloped	to	explore	how	PAP	therapy	provides	clinical	improvement	
in nightmare disorder (Bahammam et al., 2013; Krakow et al., 2000), 
especially against the background that many patients do not toler‐
ate	PAP	therapy	 (Jaoude	et	al.,	2015);	nonetheless,	a	 recent	study	
showed higher than usual adherence rates in PTSD patients using 
advanced	PAP	modes	such	as	auto‐bilevel	or	adaptive	servo‐venti‐
lation	(Krakow,	Obando,	Ulibarri,	&	Mciver,	2017).	Furthermore,	the	
possibilities of lucid dreaming as treatment deserve more attention. 
If possible, one could develop technologies that reliably allow a direct 
modification of dreaming while it occurs. Speculatively, these tech‐
nologies may prove more effective than changing the nightmare plot 
during the day. Currently, the necessity of becoming lucid remains 
in doubt because many patients fail to become lucid (Spoormaker & 
Van Den Bout, 2006), and because the mere introduction to the con‐
cept of lucid dreaming may itself bring about some relief (Holzinger 
et al., 2015).
Studies that address the effects of psychodynamic approaches 
are lacking. Relatedly, there is little research on effects of nightmare 
treatment in relation to the content of nightmares. Results obtained 
from	a	large	sample	(N=1214)	of	most	recent	nightmares	indicated	
that	the	topics	of	danger	and	loss	of	significant	others	are	frequently	
named, although they are not well represented in the diagnostic 
criteria (Mathes & Schredl, 2014) and it is not yet clear whether 
nightmare treatment works as well for these topics as for other 
nightmare topics. In addition, several nightmares included suicidal 
themes and should be considered more specifically against the back‐
ground of the cathartic functions the nightmares may have: do the 
occurence or treatment of such nightmares help to prevent suicide? 
Thus, nightmare content analyses should focus on possible "affect‐
regulating functions" of nightmares (Moser & Von Zeppelin, 1996). 
Furthermore, an evaluation of the specific life situation in which the 
nightmare occurred may offer insights into the precise nature of re‐
lated	underlying	conflicts	(c.f.	Lansky	&	Bley,	1995),	and	changes	in	
nightmare content during therapy may offer prognostic information 
(Mellman	et	al.,	2001;	Terr,	1983).	Analogies	between	dream	content	
and therapeutic processes, current life situation and interpersonal 
patterns of a patient can help to enhance awareness of significant 
current	experiences	(Wittmann	&	De	Dassel,	2015).
Finally, to the best of our knowledge, there is no research on treat‐
ment approaches that target maladaptive beliefs, idiosyncratic mod‐
els of meaning and false self‐ascriptions. Thus, it remains to be tested 
whether association splitting helps to demolish gridlocked nightmare 
scripts	beyond	and	above	IRT.	Association	splitting,	which	was	originally	
developed to treat obsessive thoughts in obsessive compulsive disor‐
der	(OCD,	Moritz,	Jelinek,	Klinge,	&	Naber,	2007)	but	was	also	effec‐
tive in alleviating other symptoms such as unwanted intrusive thoughts 
(Rodríguez‐Martín,	Moritz,	Molerio‐Pérez,	&	Gil‐Pérez,	2013),	may	be	a	
particularly good candidate for future research. Similarly, Harvey et al.'s 
(2005) cognitive restructuring approach may help patients to alter as‐
sumptions such as nightmares foretell the future or that nights with 
nightmares make it impossible to concentrate on work and life issues 
the	next	day.	It	remains	to	be	investigated	whether	such	strategies	are	
better applied as a stand‐alone treatment, as an add‐on method or as a 
combined approach.
6.3 | Future perspectives regarding 
subpopulations of nightmare sufferers
6.3.1 | The case of PTSD patients
To date, the majority of trauma survivors with PTSD receiving psy‐
chotherapy, such as trauma‐focused CBT, are treated with a focus 
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on their daytime symptoms. It is assumed that improvements gen‐
eralize to symptoms at night (i.e. sleep disturbances) and this is sup‐
ported	by	 initial	evidence	 (Woodward	et	al.,	2017).	 IRT	 treatment,	
on the other hand, mainly addresses night‐time symptoms and treat‐
ment gains, in turn, were found to generalize to daytime symptoms 
(Krakow, Hollifield et al., 2001). Further randomized controlled trials 
are	needed	to	better	identify	to	what	extent	the	treatment	of	day‐
time PTSD symptoms generalizes to nightmare symptoms and vice 
versa. Moreover, it would be useful to establish predictors of treat‐
ment response and determine which patients are more likely to re‐
spond to one treatment compared to another. So far, there is limited 
knowledge about the effects of combining treatments.
With regard to a stepped‐care approach and given that IRT inter‐
ventions	can	be	delivered	quickly	and	easily,	 future	studies	should	
establish the potential benefit of providing a brief course of IRT in 
combination with, or possibly prior to, trauma‐focused psychother‐
apy	(Nadorff	et	al.,	2014).	By	improving	sleep	quality,	PTSD	patients	
may also benefit from improved memory encoding and memory 
consolidation (Diekelmann, Wilhelm, & Born, 2009; Walker & 
Stickgold, 2006), as suggested by findings that sleep reshapes brain 
processes involved in learning and memory (Walker & Stickgold, 
2006).	 Improvements	 in	sleep	quality	were	 found	to	 reduce	PTSD	
symptoms (Ho et al., 2016) and this process may be moderated by 
cognitive appraisal, which was found to precede changes in PTSD 
symptoms (Kleim et al., 2013). It is conceivable that following effec‐
tive IRT treatment, a number of key PTSD symptoms would already 
be normalized. Remaining symptoms could be treated using trauma‐
focused CBT or other evidence‐based treatment approaches (see 
Figure 2), with a potentially reduced number of treatment sessions. 
Conducting IRT prior to trauma‐focused CBT may reward and mo‐
tivate patients and limit unwanted adverse effects that are some‐
times	caused	by	longer,	more	demanding,	more	complex	and	more	
distressing trauma‐focused interventions. Indeed, there are ongoing 
clinical trials investigating the effects of treating nightmares as a 
first‐line intervention for PTSD, as well as the effects in reducing sui‐
cidal	 ideation	 (e.g.	https://tango.uthscsa.edu/ssads/507,	University	
of	Texas;	Nadorff	et	al.,	2014).
To date, there are no treatment algorithms, no stepped‐care rec‐
ommendations and insufficient empirical evidence to recommend 
whether IRT or CBT for PTSD may be best for starting treatment. 
Future studies should determine the optimal choice and timepoint 
for IRT within a PTSD treatment regimen. In addition, interven‐
tions	 for	 PTSD	 are	 emerging	 that	 offer	 non‐exposure	 options	 for	
patients	and	therapists	who	are	unable	to	engage	in	exposure	and	
who	thus	prefer,	for	example,	imagery‐based	or	mindfulness‐based	
interventions. Future studies are needed to derive reliable treatment 
algorithms and treatment choices for specific patient characteris‐
tics, including information on potential synergistic effects of both 
nightmare interventions and trauma‐focused CBT or similar first‐line 
PTSD treatments.
6.3.2 | The case of different patient populations
Although	nightmares	have	been	shown	to	be	associated	with	many	
forms of psychopathology, such as schizophrenia, borderline per‐
sonality	disorder	and	dissociative	disorders,	little	research	has	exam‐
ined the impact of nightmare treatments on these disorders (Swart 
et	al.,	2013;	Van	Schagen	et	al.,	2017).	Future	research	may	also	help	
clarify why treated patients with diverse other mental complaints 
do not benefit as much as patients without multiple comorbidities 
(Thünker & Pietrowsky, 2012) and elucidate the effects of nightmare 
treatment in patients who suffer from other chronic diseases (e.g. 
epilepsy and pain disorders). More studies are needed to shed light 
on precisely how the treatment of nightmare disorder affects the 
F I G U R E  2  Frequently	applied	trauma‐focused	interventions	and	proposed	alternative	approaches
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other physical and mental complaints of patients (e.g. are depressive 
symptoms reduced by treating nightmares?).
Approaches	 to	 treating	 refugees	often	 fail	 to	address	 the	 spe‐
cific needs of trauma‐affected refugees as the latter often suffer 
from prolonged, repeated, cross‐generational and, often, non‐ver‐
balizable trauma, as well as from stress during and after migration, 
including uncertainty about asylum status and residence, concerns 
about family members still unsafe in their home country, cultural 
and language difficulties, and perceived discrimination and racism 
(Boynton	 et	al.,	 2009;	 Crumlish	 &	 O'rourke,	 2010;	 Palic	 &	 Elklit,	
2011). With respect to different age groups, the special needs of un‐
accompanied young refugees should be highlighted. Further, studies 
on the treatment of sleep disturbances and nightmares in refugees 
suffering	from	PTSD	and	sleep	disorders	are	lacking	and	require	fu‐
ture attention. Challenges to overcome are the lack of availability of 
translated standardized instruments and the optimal employment of 
translators. Because of language and cultural barriers, trials compar‐
ing pharmacological and psychological treatment are of particular in‐
terest	(Sandahl,	Jennum,	Baandrup,	Poschmann,	&	Carlsson,	2017).
Most studies have addressed adults but have not compared age 
groups;	 for	 example,	 the	 effects	 of	 treating	 nightmare	 disorder	 in	
children and adolescents are rarely studied. Yet given the promising 
results for adult patients and early studies in adolescents, the use 
of IRT for treating nightmares in children and adolescents should 
receive	 high	 priority.	 Nightmare	 treatment	 should	 be	 adapted	 for	
various age groups, such as toddlers and infants, schoolchildren, 
adolescents and students of an older age, because early treatment 
onset may help to prevent young people from developing chronic 
nightmare disorder.
6.4 | Future perspectives regarding integration 
into the healthcare system
The rarity of screening for nightmares within the healthcare sys‐
tem, together with the commonality of patients who do not com‐
plain about their nightmares to healthcare providers, has caused 
innumerable patients to go untreated. Thus, one major focus in fu‐
ture research should be on understanding these diagnostic short‐
comings	and	how	to	overcome	them.	This	will	require	two	policy	
objectives: (a) make screening more efficient so as to fit within 
a primary care or paediatrician visit and (b) educate healthcare 
professionals	so	they	are	equipped	to	make	appropriate	referrals.	
Given that the presence of nightmares is either comorbid with 
severe	forms	of	psychopathology	or	 is	an	exacerbating	 influence	
on	other	mental	 disorders	 (Van	 Schagen	 et	al.,	 2017),	 disturbing	
dreams may serve as an alarm signal to practitioners that an indi‐
vidual needs mental health treatment. On the other hand, if night‐
mares are a simple byproduct of normal childhood development, 
guidelines should be developed to help paediatricians determine 
whether nightmares should be addressed or not. In short, we sug‐
gest that referrals for mental health evaluations are often war‐
ranted	for	nightmares	when	suffering	exceeds	the	normal	bounds	
of developmental change.
In the attempt to improve access to treatment, low‐threshold 
interventions such as telephone counselling (Schredl et al., 2016), 
Internet‐based applications and self‐help approaches (Gieselmann 
et	al.,	 2017;	 Lancee	 et	al.,	 2010a)	 should	 be	 further	 developed	
and offered to the general public. There is an abundance of ev‐
idence that Internet‐based treatment is effective, with effect 
sizes comparable to those of face‐to‐face treatments; such novel 
approaches may help with disseminating, simplifying and, per‐
haps,	 increasing	the	effects	of	 treatments	 (Andersson,	Cuijpers,	
Carlbring, Riper, & Hedman, 2014; Cuijpers, Kleiboer, Karyotaki, 
&	Riper,	2017).	At	the	same	time,	such	Internet‐based	approaches	
bring about new challenges of data security, ethics, legal respon‐
sibility, the availability of professionals in emergencies, and the 
integration of such treatments into the mental healthcare system 
in	 accordance	 with	 existing	 rules	 of	 professional	 conduct	 and	
compensation.
In	 sum,	 there	 are	 numerous	 research	 questions	 that	 remain	
unanswered concerning the aetiology of nightmare disorder, the 
improvement of nightmare treatments, the application of night‐
mare treatment to various subpopulations and the integration of 
nightmare treatments into the healthcare system. Prompt atten‐
tion	to	these	outstanding	questions	will	enhance	our	understand‐
ing of nightmare suffering and will facilitate the delivery of mental 
healthcare to many underserved populations. We hope that the 
current consensus paper helps to highlight the nature of the con‐
tinuing obstacles and to stimulate much‐needed research in the 
field.
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